[REGN] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 246.76%
YoY- 12.60%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 2,936,200 3,452,800 2,294,000 2,048,400 1,663,496 1,500,673 1,220,122 15.75%
PBT 1,509,800 1,816,600 998,300 768,500 635,861 565,605 365,881 26.63%
Tax 194,100 184,400 156,200 98,900 41,206 177,288 101,077 11.48%
NP 1,315,700 1,632,200 842,100 669,600 594,655 388,317 264,804 30.61%
Tax Rate -12.86% -10.15% -15.65% -12.87% -6.48% -31.34% -27.63% -
Total Cost 1,620,500 1,820,600 1,451,900 1,378,800 1,068,841 1,112,356 955,318 9.20%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 44.81 47.27 36.71 32.69 35.75 25.88 21.70 12.83%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS 11.66 15.37 7.98 6.12 5.51 3.64 2.53 28.98%
EPS Diluted 11.66 14.33 7.39 5.86 5.17 3.32 2.27 31.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.